MM-P02-01

N/A

Report date: 2024/11/29 15:12:19

Base Information

Drug NameMM-P02-01
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGrowth hormone ligand
TargetsGrowth hormone
Therapy Area/IndicationsMeier-Gorlin syndromeGrowth Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMyungmoon Pharm Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyungmoon Pharm Co
Active IndicationsN/A
Inactive IndicationsMeier-Gorlin syndromeGrowth Disorders

Other Information

ATC CodeN/A
Related LinksN/A